Nicotinic replacement therapy brand Nicolette has introduced its new oral spray smoking cessation aid, 'Nicolette QuickMist.' This marks the first new formulation added in 20 years since the launch of gum and patches.
Kenview Korea Sales Co., Ltd. announced on the 30th that it will launch the 'Nicolette QuickMist' oral spray in the domestic market on October 1. This new formulation is the first oral spray nicotine replacement therapy (NRT) to be introduced in South Korea since Nicolette launched gum and patches in 2007.
Nicolette QuickMist is an over-the-counter medication designed to alleviate smoking cravings and nicotine withdrawal symptoms. Unlike gum or patches, it is sprayed directly into the mouth, allowing nicotine to be absorbed through the oral mucosa, either inside the cheek or under the tongue.
The company stated, "Using two sprays, the effect on reducing smoking cravings begins approximately 30 seconds after use, with blood nicotine levels reaching their peak in about 10 minutes."
In light of recent regulations classifying e-cigarettes as tobacco products and ongoing debates about their safety, the company noted that clinical trials have confirmed the product's effectiveness in reducing cravings among e-cigarette users. In a randomized, placebo-controlled trial involving e-cigarette users, the nicotine oral spray significantly reduced the desire to use e-cigarettes compared to the placebo, starting 30 seconds after administration and lasting up to two hours.
Bae Yeon-hee, executive director of Kenview Korea's self-care division, remarked, "With the recent increase in e-cigarette use and the diversification of smoking environments, there is a growing demand for options that can respond quickly and effectively."
Meanwhile, research findings have emerged indicating that smokers experience greater feelings of loneliness than non-smokers, with loneliness increasing over time. Dr. Keir Philip's team from Imperial College London presented these findings at the European Respiratory Society Congress 2026 held in Barcelona, Spain.
According to the research team, current smokers reported higher levels of loneliness compared to non-smokers. Even after accounting for factors such as age and gender, the difference in loneliness levels between smokers and non-smokers remained significant. Notably, current smokers experienced a more pronounced increase in loneliness over a two-year period. Similar results were observed when analyzing loneliness levels and demographic factors at the start of the study.
The research team emphasized the need to examine the health impacts of smoking not only in terms of physical ailments but also from psychosocial aspects such as social isolation and loneliness.
Kenview Korea Sales Co., Ltd. announced on the 30th that it will launch the 'Nicolette QuickMist' oral spray in the domestic market on October 1. This new formulation is the first oral spray nicotine replacement therapy (NRT) to be introduced in South Korea since Nicolette launched gum and patches in 2007.
Nicolette QuickMist is an over-the-counter medication designed to alleviate smoking cravings and nicotine withdrawal symptoms. Unlike gum or patches, it is sprayed directly into the mouth, allowing nicotine to be absorbed through the oral mucosa, either inside the cheek or under the tongue.
The company stated, "Using two sprays, the effect on reducing smoking cravings begins approximately 30 seconds after use, with blood nicotine levels reaching their peak in about 10 minutes."
In light of recent regulations classifying e-cigarettes as tobacco products and ongoing debates about their safety, the company noted that clinical trials have confirmed the product's effectiveness in reducing cravings among e-cigarette users. In a randomized, placebo-controlled trial involving e-cigarette users, the nicotine oral spray significantly reduced the desire to use e-cigarettes compared to the placebo, starting 30 seconds after administration and lasting up to two hours.
Bae Yeon-hee, executive director of Kenview Korea's self-care division, remarked, "With the recent increase in e-cigarette use and the diversification of smoking environments, there is a growing demand for options that can respond quickly and effectively."
Meanwhile, research findings have emerged indicating that smokers experience greater feelings of loneliness than non-smokers, with loneliness increasing over time. Dr. Keir Philip's team from Imperial College London presented these findings at the European Respiratory Society Congress 2026 held in Barcelona, Spain.
According to the research team, current smokers reported higher levels of loneliness compared to non-smokers. Even after accounting for factors such as age and gender, the difference in loneliness levels between smokers and non-smokers remained significant. Notably, current smokers experienced a more pronounced increase in loneliness over a two-year period. Similar results were observed when analyzing loneliness levels and demographic factors at the start of the study.
The research team emphasized the need to examine the health impacts of smoking not only in terms of physical ailments but also from psychosocial aspects such as social isolation and loneliness.
* This article has been translated by AI.
Copyright ⓒ Aju Press All rights reserved.